![]() |
|
Paul Y. Kim1; Reginald Manuel1; Michael E. Nesheim1,2
1Department of Biochemistry, Queen's University, Kingston, Ontario, Canada; 2Department of Medicine, Queen's University, Kingston,
Ontario, Canada
Human and bovine factor Va (FVa) function similarly in the activation of prothrombin but differently in the activation of prethrombin- 1 (Pre-1). Pre-1 activation with human FVa proceeds at about 22 percent of the rate with bovine FVa. The dependencies of initial rates on the FVa and Pre-1 concentrations indicate that the differential activity is expressed in kcat differences, rather than differences in the assembly of prothrombinase or the Km value of the substrate. The heavy and light chains of both species of FVa were separated and interspecies hybrids were constructed in the presence of Ca++. Studies of the activation of Pre-1 with these hybrids indicate that the species difference can be attributed specifically to the heavy chain of FVa. Analyses of the reactions by SDS-PAGE indicated that cleavage at Arg271 occurs at about the same rate with both species of FVa, but cleavage at Arg320 with human FVa is specifically retarded. A major difference in primary structure between the human and bovine FVa heavy chains comprises 10 residues at COOH-terminus, adjacent to the negatively charged hirudin-like DYDYQ sequence. These residues have pI values of 12.5 and 4.26 in human and bovine FVa, respectively. The lower value would complement the negatively charged DYDYQ sequence but the higher value would counteract it. Thus, we suggest that the differences in the COOH-terminus of the heavy chain are responsible for the differences in Pre-1 activation, and that it specifically influences cleavage at Arg320 in Pre-1.
prothrombin, factor Va, Coagulation factors, activation, prethrombin-1
| 1. | ||
Michael A. Bukys1, Tivadar Orban1, Paul Y. Kim2, Michael E. Nesheim2,3, Michael Kalafatis1,4 Thrombosis and Haemostasis 2008 99 3: 511-522 http://dx.doi.org/10.1160/TH07-08-0532 | ||
| 2. | ||
Subramanian Yegneswaran; Phuong M. Nguyen; Andrew J. Gale; John H. Griffin Thrombosis and Haemostasis 2009 101 1: 55-61 http://dx.doi.org/10.1160/TH08-07-0491 | ||
| 3. | ||
Kohei Tatsumi1, Kazuo Ohashi2, 5, Miho Kataoka3, Chise Tateno3, #, Masaru Shibata1, Hiroyuki Naka1, Midori Shima1, Michiyoshi Hisanaga2, Hiromichi Kanehiro2, Teruo Okano5, Katsutoshi Yoshizato3, 4, #, Yoshiyuki Nakajima2, Akira Yoshioka1 Thrombosis and Haemostasis 2008 99 5: 883-891 http://dx.doi.org/10.1160/TH07-09-0559 | ||